サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：結核ワクチン治療市場規模、シェア、成長分析、ワクチンの種類別、治療の種類別、エンドユーザー別、年齢層別、地域別 - 産業予測、2025年～2032年
市場調査レポート
商品コード
1772699

結核ワクチン治療市場規模、シェア、成長分析、ワクチンの種類別、治療の種類別、エンドユーザー別、年齢層別、地域別 - 産業予測、2025年～2032年

Tuberculosis Vaccine Treatment Market Size, Share, and Growth Analysis, By Vaccine Type (BCG, Recombinant), By Treatment Type (Preventive, Therapeutic), By End-User, By Age Group, By Region - Industry Forecast 2025-2032

出版日
発行
SkyQuest
ページ情報
英文 191 Pages
納期
3～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.42円
結核ワクチン治療市場規模、シェア、成長分析、ワクチンの種類別、治療の種類別、エンドユーザー別、年齢層別、地域別 - 産業予測、2025年～2032年
出版日: 2025年07月10日
発行: SkyQuest
ページ情報: 英文 191 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

結核ワクチン治療の世界市場規模は、2023年に5億米ドルと評価され、2024年の5億2,000万米ドルから2032年には7億2,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは4.1％で成長する見通しです。

結核ワクチン治療市場は、結核の有病率の増加と結核を取り巻く意識の高まりにより大きな成長を遂げています。患者数が増加するにつれて、効果的な予防法、特にワクチンの需要が高まっています。教育イニシアティブや政府主導の公衆衛生キャンペーンは、結核に関する意識を高め、結核に関連するリスクやワクチン接種の利点を強調する上で極めて重要です。さらに、ヘルスケアインフラの進歩により、診断能力やワクチン接種サービスへのアクセスが向上し、結核の早期発見と介入が容易になっています。これらの要因が相まって、結核ワクチン治療は世界の健康状況において極めて重要な要素として位置づけられ、市場の旺盛な需要を牽引しています。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数（2024年）
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • ケーススタディ

結核ワクチン治療市場規模：ワクチンの種類別& CAGR（2025-2032）

  • 市場概要
  • BCG
  • 組み換え
  • 生弱毒化
  • 不活性化

結核ワクチン治療市場規模：治療の種類別& CAGR（2025-2032）

  • 市場概要
  • 予防
  • 治療

結核ワクチン治療市場規模：エンドユーザー別& CAGR（2025-2032）

  • 市場概要
  • 病院
  • クリニック
  • 調査機関
  • その他

結核ワクチン治療市場規模：年齢層別& CAGR（2025-2032）

  • 市場概要
  • 小児
  • 成人

結核ワクチン治療市場規模：地域別& CAGR（2025-2032）

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング（2024年）
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析（2024年）
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較（2022-2024年）

主要企業プロファイル

  • Xykon
  • Merck and Co
  • Pfizer
  • Aeras
  • Antabio
  • KNCV Tuberculosis Foundation
  • Inovio Pharmaceuticals
  • Bavarian Nordic
  • Bill and Melinda Gates Foundation
  • Vaxart
  • Serum Institute of India
  • Emergent BioSolutions
  • GlaxoSmithKline

結論と提言

目次
Product Code: SQMIG35I2406

Global Tuberculosis Vaccine Treatment Market size was valued at USD 0.5 billion in 2023 and is poised to grow from USD 0.52 billion in 2024 to USD 0.72 billion by 2032, growing at a CAGR of 4.1% during the forecast period (2025-2032).

The tuberculosis vaccine treatment market is experiencing significant growth due to the increasing prevalence of tuberculosis and the heightened awareness surrounding the disease. As more cases emerge, the demand for effective prevention methods, particularly vaccines, is intensifying. Educational initiatives and government-led public health campaigns are pivotal in raising awareness about tuberculosis, emphasizing the risks associated with it and the benefits of vaccination. Furthermore, advancements in healthcare infrastructure are improving diagnostic capabilities and the accessibility of vaccination services, facilitating early detection and intervention for tuberculosis. Collectively, these factors are driving robust demand in the market, positioning tuberculosis vaccine treatments as a crucial element in the global health landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Tuberculosis Vaccine Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Tuberculosis Vaccine Treatment Market Segments Analysis

Global Tuberculosis Vaccine Treatment Market is segmented by Vaccine Type, Treatment Type, End-User, Age Group and region. Based on Vaccine Type, the market is segmented into BCG, Recombinant, Live Attenuated and Inactivated. Based on Treatment Type, the market is segmented into Preventive and Therapeutic. Based on End-User, the market is segmented into Hospitals, Clinics, Research Institutes and Others. Based on Age Group, the market is segmented into Pediatric and Adult. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Tuberculosis Vaccine Treatment Market

The rise in awareness surrounding tuberculosis treatments plays a crucial role in driving the global tuberculosis vaccine treatment market. As public knowledge of TB risks and the significance of vaccination grows, it fosters greater acceptance and demand for vaccines. Health education initiatives and outreach efforts contribute to a better understanding of prevention methods, encouraging timely immunization. This heightened awareness supports government initiatives and financial backing, ultimately leading to improved vaccine coverage. Such developments are particularly vital in regions heavily burdened by TB, where effective control measures are essential to combat the disease and boost the tuberculosis vaccine market's growth.

Restraints in the Global Tuberculosis Vaccine Treatment Market

The Global Tuberculosis Vaccine Treatment market faces significant challenges due to the limited effectiveness of the BCG vaccine in preventing pulmonary tuberculosis, particularly in adolescents and adults. While the BCG vaccine is effective against severe forms of TB in young children, its efficacy diminishes with age and offers inconsistent protection in the adult population. This reduced effectiveness leads to a decline in confidence and demand for the vaccine, highlighting a crucial need for innovative and enhanced vaccine options. Consequently, this limitation hampers market growth and complicates global efforts to control and manage tuberculosis effectively.

Market Trends of the Global Tuberculosis Vaccine Treatment Market

The global tuberculosis vaccine treatment market is witnessing a transformative trend centered around the development of novel vaccines that aim to address the limitations of the traditional BCG vaccine. As researchers explore innovative methodologies-including live attenuated, subunit, viral-vectored, and mRNA vaccine approaches-there is a growing emphasis on enhancing efficacy against both active and latent TB, as well as drug-resistant strains. Advances in genetic engineering and immunology are facilitating this clinical progress, fostering optimism for the emergence of more effective and long-lasting TB vaccines in the coming years, thereby reshaping strategies for tuberculosis prevention and control worldwide.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Case Studies

Global Tuberculosis Vaccine Treatment Market Size by Vaccine Type & CAGR (2025-2032)

  • Market Overview
  • BCG
  • Recombinant
  • Live Attenuated
  • Inactivated

Global Tuberculosis Vaccine Treatment Market Size by Treatment Type & CAGR (2025-2032)

  • Market Overview
  • Preventive
  • Therapeutic

Global Tuberculosis Vaccine Treatment Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Clinics
  • Research Institutes
  • Others

Global Tuberculosis Vaccine Treatment Market Size by Age Group & CAGR (2025-2032)

  • Market Overview
  • Pediatric
  • Adult

Global Tuberculosis Vaccine Treatment Market Size & CAGR (2025-2032)

  • North America (Vaccine Type, Treatment Type, End-User, Age Group)
    • US
    • Canada
  • Europe (Vaccine Type, Treatment Type, End-User, Age Group)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Vaccine Type, Treatment Type, End-User, Age Group)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Vaccine Type, Treatment Type, End-User, Age Group)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Vaccine Type, Treatment Type, End-User, Age Group)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Xykon
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck and Co
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pfizer
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Aeras
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Antabio
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • KNCV Tuberculosis Foundation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Inovio Pharmaceuticals
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bavarian Nordic
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bill and Melinda Gates Foundation
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vaxart
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Serum Institute of India
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Emergent BioSolutions
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GlaxoSmithKline
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations